Overview
News
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Backers
1
Taiho Ventures
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
Registers and programsofficial lists and records that name the company
Legal entity Us Breakpoint Therapeutics GmbH its site
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
Akagera MedicinesFounded 2018 • 51-200 employees
AKAGERA Medicines HOME Mission Statement SCIENCE TEAM BOARD OF DIRECTORS AKAGERA MEDICINES, AFRICA SCIENCE ADVISORY BOARD BUSINESS ADVISORY…
Kranus Health51-200 employees • 6 roles
0 Medical Advisory Board. The medical advisory board of Kranus Health consists of highly qualified and renowned physicians with extensive…
Company Management Team Board of Directors Scientific Advisory Board Clinical Advisory Board Company History Investors Science Biology…
About Us Senior Management Team Board of Directors Clinical Advisory Board Technology Pipeline Overview Migaldendranib (MGB) News Resources…
Omnix MedicalSeries C $25M · 11 mo ago • Founded 2015 • 11-50 employees
OUR TEAM FOUNDERS Dr. Moshik Cohen-Kutner Co-Founder And CEO Linkedin Dr. Niv Bachnoff Co-Founder And CSO Linkedin BOARD OF DIRECTORS Dr…
TelescentVenture round $13.3M · 5 yr ago • 11-50 employees
Home Products G5 NTM Use Cases Technology Testimonials News & Blog Latest News Blog Company Company Board of Directors Advisory Board…

Overview

Advisory Board Giovanni Mariggi, Director Giovanni is Partner and a member of the co-founding team of Medicxi. He serves on the boards of several biotech companies, including Vicebio, Vaderis, Gadeta and Aura Biosciences (AURA).

News

Blog 9 months ago
DDR Inhibitors Summit 2026
DDR Inhibitors Summit Boston, USA 27-29 January 2026
Read more
Report
Blog 9 months ago
Breakpoint Therapeutics Announces Oral Presentation at the DDR Inhibitors Summit
Breakpoint Therapeutics GmbH ("Breakpoint"), a company dedicated to the discovery and development of drugs targeting the DNA Damage Response (DDR), announced today that it will present preclinical data from its polymerase theta (Pol θ / POLQ) inhibitor pr
Read more
Report
Blog 11 months ago
London Life Sciences Week
London Life Sciences Week London, UK 18-20 November 2025
Read more
Report
Blog 11 months ago
BIO-Europe 2025
BIO-Europe Vienna, Austria 3-5 November 2025
Read more
Report
Blog 12 months ago
Boston CEO - Longwood Healthcare Leaders
Boston CEO Longwood Healthcare Leaders Boston, USA 27-28 October 2025
Read more
Report
Blog 12 months ago
EORTC-NCI-AACR international conference on molecular targets and cancer therapeutics
EORTC-NCI-AACR international conference on molecular targets and cancer therapeutics Boston, USA 22-26 October 2025
Read more
Report
Blog 12 months ago
ESMO Congress
ESMO Congress Berlin, Germany 17-21 October 2025
Read more
Report
Blog 1 year ago
RSC-BMCS / SCI 23rd Medicinal Chemistry Symposium
RSC-BMCS/SCI 23rd Medicinal Chemistry Symposium Cambridge, UK 14-17 September 2025
Read more
Report
Blog 1 year ago
Fusion conference: Targeting the DNA Damage Response for Cancer
Fusion conference: Targeting the DNA Damage Response for Cancer Lisbon, Portugal 29 June-02 July 2025
Read more
Report
Blog 1 year ago
BIO International Convention 2025
BIO International Convention Boston, USA 16-19 June 2025
Read more
Report

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Hamburg Germany
HQ
Contact Us
22419 Hamburg (Germany)
company site